PPA
UTHR icon

Parametric Portfolio Associates’s United Therapeutics UTHR Stock Holding History

Parametric Portfolio Associates’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$32M Sell
178,269
-7,042
-4% -$1.34M 0.02% 734
2021
Q4 		$40M Sell
185,311
-3,055
-2% -$600K 0.02% 643
2021
Q3 		$34.8M Sell
188,366
-29,325
-13% -$5.78M 0.02% 681
2021
Q2 		$39.1M Sell
217,691
-16,883
-7% -$3.22M 0.02% 662
2021
Q1 		$39.2M Sell
234,574
-21,520
-8% -$3.59M 0.02% 722
2020
Q4 		$38.9M Buy
256,094
+24,438
+11% +$3.21M 0.02% 652
2020
Q3 		$23.4M Buy
231,656
+11,444
+5% +$1.26M 0.02% 805
2020
Q2 		$26.6M Buy
220,212
+17,347
+9% +$1.95M 0.02% 728
2020
Q1 		$19.2M Buy
202,865
+5,999
+3% +$570K 0.02% 802
2019
Q4 		$17.3M Sell
196,866
-4,648
-2% -$409K 0.01% 1082
2019
Q3 		$16.1M Buy
201,514
+46,302
+30% +$3.73M 0.01% 1081
2019
Q2 		$12.1M Sell
155,212
-11,804
-7% -$1.1M 0.01% 1302
2019
Q1 		$19.6M Sell
167,016
-4,667
-3% -$544K 0.02% 918
2018
Q4 		$18.7M Sell
171,683
-3,252
-2% -$377K 0.02% 854
2018
Q3 		$22.4M Buy
174,935
+7,146
+4% +$884K 0.02% 822
2018
Q2 		$19M Sell
167,789
-3,287
-2% -$361K 0.02% 886
2018
Q1 		$19.2M Sell
171,076
-4,024
-2% -$511K 0.02% 846
2017
Q4 		$25.9M Buy
175,100
+2,039
+1% +$259K 0.03% 642
2017
Q3 		$20.3M Buy
173,061
+13,370
+8% +$1.71M 0.02% 729
2017
Q2 		$20.7M Sell
159,691
-8,943
-5% -$1.12M 0.02% 656
2017
Q1 		$22.8M Buy
168,634
+14,920
+10% +$2.26M 0.03% 543
2016
Q4 		$22M Buy
153,714
+21,116
+16% +$2.7M 0.03% 556
2016
Q3 		$15.7M Sell
132,598
-19,187
-13% -$2.31M 0.02% 679
2016
Q2 		$16.1M Sell
151,785
-150,152
-50% -$16.7M 0.03% 633
2016
Q1 		$33.6M Sell
301,937
-199,606
-40% -$25.3M 0.05% 358
2015
Q4 		$78.5M Sell
501,543
-46,871
-9% -$6.82M 0.13% 151
2015
Q3 		$72M Buy
548,414
+371,428
+210% +$59.6M 0.14% 152
2015
Q2 		$30.8M Sell
176,986
-3,376
-2% -$607K 0.06% 325
2015
Q1 		$31.1M Buy
180,362
+35,983
+25% +$5.49M 0.06% 323
2014
Q4 		$18.7M Sell
144,379
-26,753
-16% -$3.45M 0.04% 482
2014
Q3 		$22M Buy
171,132
+29,342
+21% +$3.02M 0.05% 399
2014
Q2 		$12.5M Buy
141,790
+2,920
+2% +$281K 0.03% 642
2014
Q1 		$13.1M Sell
138,870
-7,604
-5% -$778K 0.03% 600
2013
Q4 		$16.6M Buy
146,474
+4,550
+3% +$410K 0.04% 486
2013
Q3 		$11.2M Buy
141,924
+24,329
+21% +$1.78M 0.03% 613
2013
Q2 		$7.74M Buy
+117,595
New +$7.58M 0.02% 746

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Parametric Portfolio Associates's UTHR Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its United Therapeutics (UTHR) stake by 3.8% in Q1 2022, selling an estimated $1.34M and leaving 178,269 shares worth $32M. The position accounts for 0.02% of the portfolio, ranked #734.

Parametric Portfolio Associates first reported a position in UTHR in Q2 2013 and has held it in 36 quarters since. The position peaked at $78.5M in Q4 2015. 427 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.

  • Parametric Portfolio Associates held 178,269 shares of United Therapeutics worth $32M as of Q1 2022.
  • Parametric Portfolio Associates sold 7,042 United Therapeutics shares in Q1 2022, an estimated $1.34M.
  • United Therapeutics made up 0.02% of Parametric Portfolio Associates's portfolio in Q1 2022, its #734 holding.
  • Parametric Portfolio Associates first reported a position in United Therapeutics in Q2 2013 and has held it in 36 quarters since.
  • Parametric Portfolio Associates's United Therapeutics position peaked at $78.5M in Q4 2015.
  • 427 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.